Publications by authors named "Bryan Do"

Claim this Profile
E
Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma.
Jessie Lu, Bryan Do, Brian Primeaux

J Oncol Pharm Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing second line and beyond therapies for primary central nervous system lymphomas.
Brian Primeaux, Chelsea Luo, Erin K Yeung, Caitlin Linger, Sheree Chen, Bryan Do

Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience.
Katharine L Lewis, Collin K Chin, Kate Manos, John Casey, Nada Hamad, Bryan Do

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.
Paolo Strati, Sairah Ahmed, Partow Kebriaei, Loretta J Nastoupil, Catherine M Claussen, Bryan Do

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma.
Michael J Buege, Bryan Do, Hans C Lee, Donna M Weber, Sandra B Horowitz, Brandon R Shank

Cancer Treat Res Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T Cells in Hematologic Malignancies.
Brandon R Shank, Bryan Do, Adrienne Sevin, Sheree E Chen, Sattva S Neelapu

Pharmacotherapy· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
Dai Chihara, Jason R Westin, Yasuhiro Oki, Mohamed A Ahmed, Bryan Do

Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib for treatment of B-cell malignancies.
Bryan Do, Morgan Mace, Amber Rexwinkle

Am J Health Syst Pharm· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis